• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Market Movers
    Share Market Today
    Top Gainers
    Top Losers
    Stocks
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Market Movers
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Sanstar Limited IPO: Exploring Key Competitive Strengths

  •  4 min read
  •  1,109
  • 0s ago
Sanstar Limited IPO: Exploring Key Competitive Strengths

Sanstar Limited is all set to launch its initial public offering (IPO) on July 19. The IPO, consisting of a fresh issue and an offer for sale, will close on July 23. As the IPO approaches, it is crucial for you, as an investor, to know the company’s key strengths, based on which the company will determine the offer price.

Given below are the core strengths of Sanstar Limited:

  • A premier Indian manufacturer of maize-based speciality products and ingredient solutions with a diverse product portfolio

According to a Frost & Sullivan report, Sanstar Limited is India's fifth largest manufacturer of maize-based speciality products and ingredient solutions. It commenced commercial production from its facilities at Kutch and Dhule in 2006 and 2017, respectively, and has grown its business to the current scale with an installed capacity of 363,000 tons per annum.

It also offers a diversified portfolio of speciality products and ingredient solutions including liquid glucose, dried glucose solids, maltodextrin powder, dextrose monohydrate, native maize starch, modified maize starches, and co-products like germs, gluten, fibre, and enriched protein, amongst others.

  • Speciality products and ingredients solutions player catering to diverse industry segments

Sanstar Limited is a specialty products and ingredients solutions company-manufacturing native and modified maize starches, derivatives, and co-products. Its manufacturing facilities, export presence and exposure in over 49 countries, and track record of commercialising and scaling up new products position it advantageously to capture the requirements of diverse end-user industrial sectors.

  • Strategically located, sustainability-driven, state-of-the-art manufacturing facilities

The company's Dhule facility in Maharashtra is a strategically located, state-of-the-art, highly automated, sustainability-focused facility with ample scope for expansion. The facility is located on an aggregate land area of 7.90 million square feet (approximately 181 acres), of which 2.46 million square feet (approximately 56 acres) is available for future expansion. It is highly automated and equipped with Supervisory Control and Data Acquisition ('SCADA') and PLC Automation Systems, enabling quicker turnaround time and higher manufacturing rates.

  • Global presence in a market with high entry barriers

Sanstar Limited has sold its products to 49 countries across Asia, Africa, the Middle East, Europe, North America, South & Central America, and Oceania regions during the fiscal 2024. It is recognised as a 'Two Star Export House' under the Indian Ministry of Commerce. Given the nature of the application of its products and the processes involved, its products are subject to and measured against high-quality standards and product approval systems and specifications.

The company has developed relationships with its customers over the years, established strategic, state-of-the-art manufacturing facilities, and has proven to be a reputable producer with a track record of providing high-quality products.

  • Strong financial growth along with robust performance metrics

Sanstar Limited has a strong balance sheet with growing cash flows. The company has experienced sustained growth in various financial indicators, including revenue, profitability, cash flows, and returns, as well as consistent improvement in its balance sheet position in the last three fiscals, which has seen an increase in its net worth. It has demonstrated consistent growth in terms of revenues and profitability.

Its revenue from operations has increased at a CAGR of 45.46% from ₹ 504.402 crores in fiscal 2022 to ₹ 1067.271 crores in fiscal 2024. The company's profit after tax has grown at a CAGR of 104.79% from ₹ 15.921 crores in fiscal 2022 to ₹ 66. 767 crores in fiscal 2024.

  • Large, diversified customer base with long-lasting relationships

The company served over 525 customers during fiscal 2024, of which over 162 were new customers. It has also established long-term relationships, and 96 customers placed repeat orders within each of the previous three fiscals.

Over the years, the company has also diversified its customer base across food, animal nutrition, and other industrial applications, such as pharmaceuticals, paper, textiles, personal care, and adhesives, amongst others.

In conclusion

Read the company’s red herring prospectus (RHP) for further details on its key strengths. The RHP will also provide insights into the company’s financial health and future strategies. Before investing, ensure you factor in your risk tolerance and financial goals.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document prior to investing. Brokerage will not exceed SEBI’s prescribed limit.

FAQs

Fresh issue consists of up to 41,800,000 equity shares.

The offer for sale consists of up to 11,900,000 equity shares.

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Open Your Demat Account Now!
+91 -

Open Your Demat Account Now!
+91 -